FDA Approves AMX0035!
If you took the Ice Bucket Challenge, you helped deliver AMX0035, the first newly developed treatment approved for ALS in years. AMX0035 slows progression of ALS and extends life for people living with ALS.
Partnerships & Initiatives
From harnessing innovative ideas, to translating concepts to therapies, to advancing treatments for people living with ALS – The ALS Association’s collaborative and global approach to funding research continues to lead to significant discoveries by top ALS scientists around the world.
Collaboration is the cornerstone of our research program. We partner with academia, industry, government, and other nonprofit organizations and lead by spurring long-lasting collaborations among researchers across all sectors, leading to globally shared data, protocols, and research samples to accelerate research progress.
Lawrence and Isabel Barnett Drug Development Program
This grant program supports preclinical drug discovery and development of treatments for ALS.
